4//SEC Filing
Eldridge George A 4
Accession 0001415889-24-010136
CIK 0001798749other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 6:00 PM ET
Size
9.2 KB
Accession
0001415889-24-010136
Insider Transaction Report
Form 4
Eldridge George A
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-04-01$2.14/sh+12,495$26,739→ 14,455 total - Sale
Common Stock
2024-04-01$31.23/sh−12,495$390,208→ 1,960 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-01−12,495→ 15,768 totalExercise: $2.14Exp: 2031-04-01→ Common Stock (12,495 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001413006
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 6:00 PM ET
- Size
- 9.2 KB